Novel Immunotherapy Targets for GBM

Cancer immunotherapies, including checkpoint inhibitor blocking antibodies and antibody drug conjugates (ADCs), currently revolutionize cancer treatment. However, a remaining challenge is the identification of tumor surfaceome (TS) targets for the design of more rational, individualized treatments. We are leveraging “proteo-genomics” to identify novel targets for development of novel immunotherapy and RNA therapeutics against cancer.

Ahmad Yakinuddin, Mohammed Azharuddin Savanur, Adnan Husain, Firoz Ahmad.